Prevention of cisplatin-induced ototoxicity in children and adolescents with cancer: a clinical practice guideline.

Address: Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Los Angeles, CA, USA; Departments of Pediatrics and Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, US.; Department of Haematology and Oncology, Great Ormond Street Hospital, London, UK.; Department of Otolaryngology-Head and Neck Surgery, Stanford University, Palo Alto, CA, USA.; Department of Pharmacy, The Hospital for Sick Children, Toronto, ON, Canada; Child Health Evaluative Sciences, Research Institute, The Hospital for Sick Children, Toronto, ON, Canada; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.; Department of Pediatric Oncology, Casa de Saude Santa Marcelina, Sao Paolo, Brazil.; Pediatric Audiology, Doernbecher Children's Hospital, Oregon Health and Science University, Portland, OR, USA.; Division of Haematology and Oncology, The Hospital for Sick Children, Toronto, ON, Canada; Pediatric Oncology Group of Ontario, Toronto, ON, Canada.; Department of Haematology and Oncology, Leeds Teaching Hospital, NHS Trust, Leeds, UK; Centre for Reviews and Dissemination, University of York, York, UK.; Division of Oncology, Royal Marsden Hospital, London, UK.; Great Ormond Street Hospital, London, UK.; London, UK.; Children's Cancer Centre, Royal Children's Hospital, Melbourne, VIC, Australia; Department of Paediatrics, Faculty of Medicine, University of Melbourne, Melbourne, VIC, Australia.; Pediatric Oncology Group of Ontario, Toronto, ON, Canada.; Child Health Evaluative Sciences, Research Institute, The Hospital for Sick Children, Toronto, ON, Canada; Division of Haematology and Oncology, The Hospital for Sick Children, Toronto, ON, Canada. Electronic address: [email protected].